RxDoctor Payments Data

Nathan Bay, MD

Family Medicine · Silverton, ORNPI 1518161546

Payments from drug & device makers

$839in general payments, 2019–2025

Across 47 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$278
  • Sanofi$90
  • Boehringer Ingelheim$77
  • Bayer$61
  • E.r. Squibb & Sons, L.L.C.$55
  • AbbVie$53
  • plus $224 from 10 others

What the payments were for

  • Speaking & faculty fees$9011%
  • Food & beverage$72987%
  • Education$202%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$839 in reported general payments places this provider in the 85th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$66,329
Medicare patients
122
Services billed
4,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban139$125,520
JardianceEmpagliflozin112$106,973
OzempicSemaglutide69$77,410
Trelegy ElliptaFluticasone/Umeclidin/Vilanter93$62,706
JanuviaSitagliptin Phosphate42$47,989
Spiriva RespimatTiotropium Bromide22$13,255
EntrestoSacubitril/Valsartan19$12,826
FarxigaDapagliflozin Propanediol15$12,786
Breo ElliptaFluticasone/Vilanterol24$12,685
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$10,245
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog34$9,775
Humalog Kwikpen U-100Insulin Lispro23$3,390
Atorvastatin Calcium359$3,251
Metoprolol Succinate219$2,886
Levothyroxine Sodium265$2,711

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$77$120,228134 claims
GSKTrelegy Ellipta, Breo Ellipta$31$75,391117 claims
MerckJanuvia$14$47,98942 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Silverton

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →